Siderophore-Antibiotic Conjugate Probe for In Vivo PET Imaging of S. aureus Infections

A heterodimeric imaging agent synthesized by linking Vancomycin and desferrioxamine B for positron emission tomography (PET) detection of Staphylococcus aureus infections. The dataset likely contains results from biochemical validation, biodistribution studies, and in vivo imaging experiments. The data was authored by Collin E. Merrick and last updated on figshare in May 2026.

Use Cases

• Validate the mechanism of action of a siderophore-antibiotic conjugate based on biochemical assay data.
• Analyze biodistribution patterns of the [68Ga][Ga(DFO-PEG-Vanco)] probe in vivo.
• Assess the specificity and sensitivity of PET imaging for Staphylococcus aureus infection detection.
• Compare probe performance against existing clinical imaging technologies for bacterial infections.

Strengths

• Dataset describes a novel, scalable synthesis of a targeted imaging probe for a clinically significant pathogen.
• The probe combines two clinically used molecules, potentially leveraging established safety profiles.
• The conjugate is labeled with 68Ga, enabling in vivo PET imaging, a standard clinical modality.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect bias inherent to the specific experimental model used.

Provenance

Source

figshare

Collection Method

Likely contains experimental data from probe synthesis, validation, and imaging studies.

Freshness

Last updated 2026-05-22 23:44:50; freshness should be verified.